No Picture
News

Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.

Acquisition adds talent and proprietary therapeutic platform to accelerate next-generation cancer immunotherapyXyphos shareholders to receive up to $665 million in structured, milestone-based acquisition

TOKYO and SOUTH SAN FRANCISCO, Calif., Dec. 26… […]

No Picture
News

GTCR and Golden Gate Capital Announce Recapitalization of Cole-Parmer Instrument Company

CHICAGO and SAN FRANCISCO and VERNON HILLS, Ill., Sept. 26, 2019 /PRNewswire/ — GTCR and Golden Gate Capital announced today that they have signed a definitive agreement to recapitalize Cole-Parmer Instrument Company (“Cole-Parmer”, or the “Company… […]